SHH and hepatocellular carcinoma: Furthermore, the SHH signaling pathway has been implicated in various aspects of HCC, including cancer development, progression, invasiveness, recurrence, metastasis, tumor microenvironment, drug resistance (such as chemotherapy and targeted therapy), radiotherapy resistance, and maintenance of cancer stem cells.